Pitre v. KeVita, Inc.

Summary

The United States District Court for the Northern District of California granted KeVita, Inc.’s motion to dismiss Yolanda Pitre’s claims under California’s Consumer Legal Remedies Act, False Advertising Law, and Unfair Competition Law. The court held that the scientific study cited in the amended complaint did not support Pitre’s allegation that the product required at least 10 grams of gum arabic to provide a prebiotic benefit, and therefore the misrepresentation and deception theories were not plausibly pleaded. The court granted leave to amend within 21 days and declined to dismiss Pitre’s requests for injunctive and other equitable relief at the pleading stage.

Holdings

1. The amended complaint failed to plausibly allege that KeVita's product contained too little prebiotic fiber or too much added sugar to provide gut-health benefits because the study cited in the complaint did not establish that ten grams of gum arabic was a minimum effective dose.
2. Although deception ordinarily presents a factual question, dismissal at the pleading stage was appropriate in this rare case because Pitre had not plausibly alleged the factual premise necessary to show that the product's gut-health representations were misleading.
3. The statement "your tummy and taste buds will thank you!" could not be treated as nonactionable puffery at the pleading stage because, viewed in context with the product's repeated references to prebiotics and gut health, the label plausibly represented that the product promoted digestive health.
4. Pitre failed to state a UCL claim under any of the unlawful, unfair, or fraudulent prongs because each theory depended on the unsupported allegation that consumers had to drink more than three cans of the product to obtain a gut-health benefit.
5. A previously deceived consumer may have Article III standing to seek injunctive relief against allegedly false advertising or labeling when she plausibly alleges that she would like to purchase the product in the future but cannot rely on its advertising or labeling.
6. The court declined to dismiss Pitre's requests for restitution and disgorgement because, at the pleading stage, a plaintiff may plead that legal remedies are inadequate or plead equitable claims in the alternative.
7. The court considered the two studies and article at issue under the incorporation-by-reference doctrine because the parties agreed that the documents could be considered, but declined to consider the remaining studies because Pitre did not show that they were described in or integral to the amended complaint.

Questions Presented

1. Whether the amended complaint plausibly alleged that KeVita's advertising and labeling were false or misleading under the CLRA, FAL, and UCL.
2. Whether the challenged label statements were nonactionable puffery.
3. Whether Pitre plausibly stated claims under the unlawful, unfair, and fraudulent prongs of the UCL.
4. Whether Pitre had Article III standing to seek injunctive relief.
5. Whether Pitre could seek restitution and disgorgement as equitable relief at the pleading stage.
6. Whether the court could consider product labels and scientific publications through judicial notice or incorporation by reference.

Disposition

other